Using cognition to predict the ability to understand medical treatment in brain and metastatic cancer.
cancer
cognition
functional ability
medical decision making
medical ethics
metastasis
oncology
Journal
Psycho-oncology
ISSN: 1099-1611
Titre abrégé: Psychooncology
Pays: England
ID NLM: 9214524
Informations de publication
Date de publication:
02 2020
02 2020
Historique:
received:
29
07
2019
revised:
21
10
2019
accepted:
27
10
2019
pubmed:
9
11
2019
medline:
6
10
2020
entrez:
9
11
2019
Statut:
ppublish
Résumé
To determine if cognition can be used to identify persons with cancer at high risk for the impaired ability to understand treatment decisions. The association between understanding treatment decisions and cognition was examined using data from 181 participants across four groups: 67 with brain metastasis, 41 with metastatic cancer that has not spread to the brain, 27 with malignant glioma, and 46 healthy controls. All diagnoses were made by board-certified oncologists and were verified histologically. Results indicated that numerous cognitive functions were associated with the ability to understand treatment decisions in persons with cancer. The following proportion of participants demonstrated impaired understanding of treatment decisions in our three patient groups: approximately 51% malignant glioma, approximately 46% brain metastasis, and approximately 24% metastatic cancer. In a combined brain cancer group, we were able to use cognitive performance to predict the impaired ability to understand treatment decisions. An impaired ability to understand treatment decisions is prevalent in persons with brain cancer and persons with metastatic cancer. Performance on a brief cognitive battery can be used to help clinicians identify patients at particular risk for impaired medical decision making.
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
406-412Informations de copyright
© 2019 John Wiley & Sons, Ltd.
Références
Appelbaum P, Grisso T. Assessing patients' capacities to consent to treatment. N Engl J Med. 1988;319(25):1635-1638.
Marson DC, Ingram KK, Cody HA, Harrell LE. Assessing the competency of patients with Alzheimer's disease under different legal standards. A prototype instrument. Arch Neurol. 1995;52(10):949-954.
Gerstenecker A, Grimsley L, Otruba B, et al. Medical decisionmaking in progressive supranuclear palsy: a comparison to other neurodegenerative disorders. Parkinsonism Relat Disord. 2019;61:77-81
Gerstenecker A, Lowry K, Myers T, et al. Medical decision-making capacity and its cognitive predictors in multiple sclerosis: preliminary evidence. J Neurol Sci. 2017;380:38-43.
Gerstenecker A, Meneses K, Duff K, Fiveash JB, Marson DC, Triebel KL. Cognitive predictors of treatment decisions in patients with newly diagnosed brain metastasis. Cancer. 2015;121(12):2013-2019.
Martin RC, Gerstenecker A, Nabors LB, Marson DC, Triebel KL. Impairment of medical decisional capacity in relation to Karnofsky Performance Status in adults with malignant brain tumor. Neurooncol Pract. 2015;2(1):13-19.
Triebel KL, Gerstenecker A, Meneses K, et al. Capacity of patients with brain metastases to make treatment decisions. Psychooncology. 2015;24(11):1448-1455.
Steward KA, Gerstenecker A, Triebel KL, et al. Twelve-month recovery of medical decision-making capacity following traumatic brain injury. Neurology. 2016;87(10):1052-1059.
Platta CS, Khuntia D, Mehta MP, Suh JH. Current treatment strategies for brain metastasis and complications from therapeutic techniques: a review of current literature. Am J Clin Oncol. 2010;33(4):398-407.
Miller AM, Applebaum AJ, Reiner A, et al. Prognostic awareness, prognostic communication, and cognitive function in patients with malignant glioma. Neuro Oncol. 2017;19(11):1532-1541.
Weitzner M, Meyers C. Cognitive functioning and quality of life in malignant glioma patients: a review of the literature. Psychooncology. 1997;6(3):169-177.
Triebel KL, Martin RC, Nabors LB, Marson DC. Medical decision-making capacity in patients with malignant glioma. Neurology. 2009;73(24):2086-2092.
Dymek M, Atchison P, Harrell L, Marson D. Competency to consent to treatment in cognitively impaired patients with Parkinson's disease. Neurology. 2001;56(1):17-24.
Gerstenecker A, Niccolai L, Marson D, Triebel KL. Enhancing medical decision-making evaluations: introduction of normative data for the Capacity to Consent to Treatment Instrument. Assessment. 2016;23(2):232-239.
Brandt J, Benedict RH. Hopkins Verbal Learning Test-Revised. Lutz, Florida: Psychological Assessment Resources, Inc.; 2001.
Wechsler D. WAIS-III Wechsler Adult Intelligence Scale-Third Edition. San Antonio, TX: The Psychological Corporation; 1997.
Ruff RM, Light RH, Parker SB, Levin HS. Benton Controlled Oral Word Association Test: reliability and updated norms. Arch Clin Neuropsychol. 1996;11(4):329-338.
Reitan R, Wolfson D. The Halstead-Reitan Neuropsychological Test Battery: Theory and Clinical Interpretation. Tucson, AZ: Neuropsychology Press; 1993.
Karnofsky D, Burchenal J. The clinical evaluation of chemotherapeutic agents in cancer. In: Macleod C, ed. Evaluation of Chemotherapeutic Agents. New York: Columbia University Press; 1949:199-205.
Gerstenecker A, Duff K, Meneses K, Fiveash JB, Nabors LB, Triebel KL. Cognitive Predictors of Reasoning through Treatment Decisions in Patients with Newly Diagnosed Brain Metastases. J Int Neuropsychol Soc: JINS. 2015;21(6):412-418.
Altman DG, Bland JM. Diagnostic tests 3: receiver operating characteristic plots. BMJ (Clinical Research Ed). 1994;309(6948):188.
Marson D, Ingram K. Competency to consent to treatment: a growing field of research. J Ethics Law Aging. 1996;2:59-63.
Vance DE, Frank JS, Bail J, et al. Interventions for cognitive deficits in breast cancer survivors treated with chemotherapy. Cancer Nurs. 2017;40(1):E11-e27.
Diamond A. Executive functions. Annu Rev Psychol. 2013;64:135-168.
Alzheimer's Association. Research consent for cognitively impaired adults: recommendations for institutional review boards and investigators. Alzheimer Dis Assoc Disord. 2004;18(3):171-175.